This report provides exclusive insights into the COVID-19 impact on the Bio-implants Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Bio-implants Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Bio-implants Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on the bio-implants market provides in-depth analysis
of segments and sub-segments in the global as well as regional bio-implants
market. The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional bio-implants market over the short term
as well as long term. The report is a comprehensive presentation of trends,
forecast and dollar values of the global bio-implants market. According to the
report, the global bio-implants market is projected to grow at a CAGR of 4.2%
over the forecast period of 2019-2025.
Bio implants are made up of
biosynthetic materials such as collagen, tissue-engineered products which
include artificial skin or tissues as well as it is used to regularize the
physiological functions. On the other hand, the manufacturer has launched many technological
advancements such as 3D printing, a nanotechnology that led to a steady evolution
of the global bio-implants market. Bio implants are used in various diseases
such as cardiovascular, neurological, orthopedic, and dental surgeries that
leading to markedly high surgical outcomes. In addition, drug-eluting stents,
hormonal implants and implantable drug pumps are also other bioactive implants
in this market.
The increasing demand of the
bio-implants for the non-surgical or minimally invasive in various medical
disciplines is the factor enhancing the growth of the market. In addition,
bio-implants are easier as a well a more effective alternative to a root canal
procedure for dental patients. Thereby, the growing number of dental patients
drives the growth of the market. For instance, in 2017, according to the global
burden of disease study 3.5 million people were affected by oral diseases such
as dental caries and various tooth problems globally. On the other hand,
according to the International Agency for Research on Cancer, oral cancer is in
the top three types of cancers in the Asia Pacific. Hence, increasing oral
cancer disease propels the growth of the bio-implants market. Rising adoption
of the sanitary lifestyle of the people is the major cause of numerous chronic
disorders such as congenital & neuropathic disorders, CVD and
osteoarthritis. This has pushed the demand for bio-implants across the globe.
For instance, in 2018, in U.s, the American Heart Association, around 836,546
death of the cardiovascular disease patient had been estimated. Increasing
technological advancement in the manufacturing of bio-implants by the
manufacturer such as 3D printing, laser technology, and nanotechnology in the
last decades are the factor thrusting the growth of the market. High cost
associated with the bio-implants yet remains one of the major restraints to
this market. Lack of favorable reimbursement issues is another factor hindering
the growth of the same market. Moreover, the rise in government funding in
healthcare offers favorable opportunities in this market.
Based on the region, North
America holds the highest market share in this market and expected to continue
its growth in the forecast period. Increasing adoption of the advanced
technologies in various medical disciplines and the growing number of surgical
procedures are the factors propelling the growth of the bio-implant in this
region. On the other hand, Europe is the second-largest market share in this
market due to the rising initiative of R&D activities and growing
orthopedic disorder in this region. Asia Pacific is expected to grow at the
highest CAGR in the forecast period due to the high incidence of spinal cord
injuries. For instance, according to Tokyo’s Keio University’s 2019 publication,
due to spinal cord injuries, more than 100,000 patients in Japan were
paralyzed. However, increasing the development and approval of the new
technology for bio-implants such as iPS technology in this country remains one
of the market opportunities for the bio-implants.
The report on global bio-implants
market covers segments such as type, material, and end user. On the basis of
type, the sub-markets include cardiovascular implants, orthopedic implants,
spinal implants, ophthalmic implants, and other implants. On the basis of
material, the sub-markets include ceramic, polymers, biomaterial metal, and
alloys. On the basis of end user, the sub-markets include hospital, research
center, and other end users.
The report provides profiles of
the companies in the market such as Stryker Corporation, BIOTRONIK, Inc.,
Dentsply Sirona, Ethicon Inc., Wright Medical Group, Inc., Orthofix
International N.V, Spinal Kinetics Inc., Zimmer Biomet, Smith & Nephew plc,
Karl Leibinger Medizintechnik, and Medtronic plc.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the bio-implants market. Moreover, the study highlights current market
trends and provides forecast from 2019-2025. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players.